Dengue is the most rapidly spreading mosquito-borne viral disease in the world. In the last 50 years, incidence has increased 30-fold with increasing geographic expansion to new countries and in the present decade, from urban to rural settings. An estimated 50 million dengue infections occur annually and approximately 2.5 billion people live in dengue endemic countries. 1 Annually, 390 million people become infected with one of four serologically distinct serotypes of dengue virus (DENV-1 to -4), through the bites of infected females of Aedes aegypti 2 This neglected tropical disease (NTD) including its severe form, dengue haemorrhagic fever have already predicted a dramatic increase of dengue in the following 30 years. 3 Previous studies indicate that dengue may have seasonal and inter-annual patterns of occurrence.
Dengue transmission dynamics can be highly heterogeneous due to the complex interactions among virus serotypes, vector, and host. Some studies have associated these periodic outbreaks with global inter-annual climatic variations such as El Niño Southern Oscillation (ENSO). 4 With the climate change there is established correlation of spread of Dengue is now a fact. In the tropical countries specially in South Asian region increase of 2 degree temperature there is increase incidence of Dengue. The duration of developmental time of adult mosquito is 30 days in 15 degree Celsius shorten to 8 days in temperature of 30 degree. Two decades before it was a disease affecting mostly children but presently Dengue is the disease affecting mostly the adults specially in Bangladesh, Indonesia, Singapore and Thailand. There is significant variance in clinical manifestations and severity of dengue infection in different age groups. DF has been known in Asia for more than a century, and its severity is largely age-dependent. This disease is mild in children and more severe in adults. Infants and children with DF have symptoms ranging from an undifferentiated fever to a mild febrile illness, sometimes associated with a rash. Older children and adults frequently suffer a more severe form with high fever, pain in various parts of the body, and a maculopapular rash. However, the infection is only rarely fatal with co-morbidities that are more likely to be present in adults than in children such as peptic ulcers and preexisting liver disease, CKD can aggravate the disease severity. Thus, proper management of dengue patients must consider the different age-specific clinical manifestations. 7 Dengue patients with severe organ involvement such as liver, kidneys, brain, or heart have been increasingly reported. These organopathies may be associated with co-infections, co-morbidities, or complications of prolonged shock. Organopathies can modify clinical presentations of dengue disease and result in missed or delayed diagnosis. 8 The factors that may have contributed to rapid changing epidemiology of DF/ DHF in South East Asia region are the challenges that need to be addressed in designing operational research and implementation strategies. Operational research is needed to answer research questions on how the efficacy, cost effectiveness, sustainability and scaling up of existing and promising new control methods can be enhanced. The major factors influencing changes in dengue Epidemiology and clinical presentations include: i) viral genotypes/subtypes with increased virulence; ii) lack of information on human population genetics and its relation with viral genome; iii) lack of information on vector ecology in micro climatic conditions; iv) viral load injected by infected mosquito; v) post infection natural immunity of the host and vi) time interval in sequential infection. 2 
